Royce & Associates LP Corcept Therapeutics Inc Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Royce & Associates LP holds 363,272 shares of CORT stock, worth $19 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
363,272
Previous 350,272
3.71%
Holding current value
$19 Million
Previous $11.4 Million
47.66%
% of portfolio
0.16%
Previous 0.11%
Shares
27 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$863 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$522 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$431 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$340 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$199 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.59B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...